Amphetamine; Amphetamine Aspartate/dextroamphetamine Sulfate Patent Expiration
Amphetamine; Amphetamine Aspartate/Dextroamphetamine Sulfate is used for managing symptoms of Attention Deficit Hyperactivity Disorder. It was first introduced by Tris Pharma Inc
Amphetamine; Amphetamine Aspartate/dextroamphetamine Sulfate Patents
Given below is the list of patents protecting Amphetamine; Amphetamine Aspartate/dextroamphetamine Sulfate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Dyanavel Xr 10 | US11590081 | Extended release amphetamine tablets | Sep 24, 2038 | Tris Pharma Inc |
| Dyanavel Xr 15 | US11590081 | Extended release amphetamine tablets | Sep 24, 2038 | Tris Pharma Inc |
| Dyanavel Xr 20 | US11590081 | Extended release amphetamine tablets | Sep 24, 2038 | Tris Pharma Inc |
| Dyanavel Xr 5 | US11590081 | Extended release amphetamine tablets | Sep 24, 2038 | Tris Pharma Inc |
| Dyanavel Xr | US11590228 | Extended release amphetamine compositions | Sep 07, 2036 | Tris Pharma Inc |
| Dyanavel Xr | US8062667 | Modified release formulations containing drug-ion exchange resin complexes | Mar 29, 2029 | Tris Pharma Inc |
| Dyanavel Xr | US10086087 | Modified release formulations containing drug-ion exchange resin complexes | Mar 15, 2027 | Tris Pharma Inc |
| Dyanavel Xr | US8597684 | Modified release formulations containing drug-ion exchange resin complexes | Mar 15, 2027 | Tris Pharma Inc |
| Dyanavel Xr | US8747902 | Modified release formulations containing drug-ion exchange resin complexes | Mar 15, 2027 | Tris Pharma Inc |
| Dyanavel Xr | US8883217 | Modified release formulations containing drug-ion exchange resin complexes | Mar 15, 2027 | Tris Pharma Inc |
| Dyanavel Xr | US9675703 | Modified release formulations containing drug - ion exchange resin complexes | Mar 15, 2027 | Tris Pharma Inc |
| Dyanavel Xr 10 | US8337890 | Modified release formulations containing drug-ion exchange resin complexes | Mar 15, 2027 | Tris Pharma Inc |
| Dyanavel Xr 10 | US8747902 | Modified release formulations containing drug-ion exchange resin complexes | Mar 15, 2027 | Tris Pharma Inc |
| Dyanavel Xr 10 | US9675704 | Modified release formulations containing drug-ion exchange resin complexes | Mar 15, 2027 | Tris Pharma Inc |
| Dyanavel Xr 15 | US8337890 | Modified release formulations containing drug-ion exchange resin complexes | Mar 15, 2027 | Tris Pharma Inc |
| Dyanavel Xr 15 | US8747902 | Modified release formulations containing drug-ion exchange resin complexes | Mar 15, 2027 | Tris Pharma Inc |
| Dyanavel Xr 15 | US9675704 | Modified release formulations containing drug-ion exchange resin complexes | Mar 15, 2027 | Tris Pharma Inc |
| Dyanavel Xr 20 | US8337890 | Modified release formulations containing drug-ion exchange resin complexes | Mar 15, 2027 | Tris Pharma Inc |
| Dyanavel Xr 20 | US8747902 | Modified release formulations containing drug-ion exchange resin complexes | Mar 15, 2027 | Tris Pharma Inc |
| Dyanavel Xr 20 | US9675704 | Modified release formulations containing drug-ion exchange resin complexes | Mar 15, 2027 | Tris Pharma Inc |
| Dyanavel Xr 5 | US8337890 | Modified release formulations containing drug-ion exchange resin complexes | Mar 15, 2027 | Tris Pharma Inc |
| Dyanavel Xr 5 | US8747902 | Modified release formulations containing drug-ion exchange resin complexes | Mar 15, 2027 | Tris Pharma Inc |
| Dyanavel Xr 5 | US9675704 | Modified release formulations containing drug-ion exchange resin complexes | Mar 15, 2027 | Tris Pharma Inc |
Amphetamine; Amphetamine Aspartate/dextroamphetamine Sulfate's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List